Asfotase alfa 80mg/0.8ml solution for injection vials
NHS hospitals in England used £51,170,112 of indicative cost of Asfotase alfa 80mg/0.8ml solution for injection vials in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 7.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Asfotase alfa 80mg/0.8ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Asfotase alfa 80mg/0.8ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| St George's Univ Hosps Foundation Nhst | £19,079,424 |
| Sheffield Teaching Hospitals Nhs Trust | £17,273,088 |
| Royal National Ortho.hospital Trust | £6,999,552 |
| Manchester University Nhs Ft | £3,612,672 |
| Sheffield Children's Nhs Ft | £1,994,496 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,251,264 |
| Oxford University Hospitals Nhs Ft | £903,168 |
| Birmingham Womans & Childrens Nhs Ft | £56,448 |
The primary-care picture
Asfotase alfa is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Asfotase alfa medicine page.